APA (7th ed.) Citation

Bradbury, A. W., Moakes, C. A., Popplewell, M., Meecham, L., Bate, G. R., Kelly, L., . . . Slinn, G. (2023). A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): An open-label, randomised, multicentre, phase 3 trial. Lancet, 401(10390), 1798. https://doi.org/10.1016/S0140-6736(23)00462-2

Chicago Style (17th ed.) Citation

Bradbury, Andrew W., et al. "A Vein Bypass First Versus a Best Endovascular Treatment First Revascularisation Strategy for Patients with Chronic Limb Threatening Ischaemia Who Required an Infra-popliteal, with or Without an Additional More Proximal Infra-inguinal Revascularisation Procedure to Restore Limb Perfusion (BASIL-2): An Open-label, Randomised, Multicentre, Phase 3 Trial." Lancet 401, no. 10390 (2023): 1798. https://doi.org/10.1016/S0140-6736(23)00462-2.

MLA (9th ed.) Citation

Bradbury, Andrew W., et al. "A Vein Bypass First Versus a Best Endovascular Treatment First Revascularisation Strategy for Patients with Chronic Limb Threatening Ischaemia Who Required an Infra-popliteal, with or Without an Additional More Proximal Infra-inguinal Revascularisation Procedure to Restore Limb Perfusion (BASIL-2): An Open-label, Randomised, Multicentre, Phase 3 Trial." Lancet, vol. 401, no. 10390, 2023, p. 1798, https://doi.org/10.1016/S0140-6736(23)00462-2.